Pre-launch · We're opening Reserve Meds to a limited first cohort. Join the waitlist ›

Aquestive Therapeutics

Aquestive Therapeutics is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Aquestive Therapeutics products.

Drugs from Aquestive Therapeutics supported via NPP

BrandGenericCategoryIndication
Libervantdiazepam buccal filmNeurologySeizure clusters, OUT OF SCOPE (DEA Schedule IV; PlatformCo does not handle controlled substances. Fatima's DEA-registered entity may pursue separately.)

How NPP access to Aquestive Therapeutics products works

Reserve Meds sources Aquestive Therapeutics products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.

Not affiliated with Aquestive Therapeutics

Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Aquestive Therapeutics.

Start a request

Start a request for a Aquestive Therapeutics product

Review & oversight. Content on this page is reviewed by Reserve Meds's clinical and regulatory team. A US-licensed pharmacist reviews every prescription before dispensing. Regulatory posture is informational, not legal advice; case-specific questions route to retained outside counsel. Review methodology ›
Last medically reviewed: .